A randomized, double-blind, multicenter, placebo-controlled study to determine the efficacy and safety of BTDS [buprenorphine transdermal deliver system] compared to placebo in subjects with moderate to severe osteoarthritic pain of the hip or knee

Trial Profile

A randomized, double-blind, multicenter, placebo-controlled study to determine the efficacy and safety of BTDS [buprenorphine transdermal deliver system] compared to placebo in subjects with moderate to severe osteoarthritic pain of the hip or knee

Completed
Phase of Trial: Phase III

Latest Information Update: 27 May 2016

At a glance

  • Drugs Buprenorphine (Primary)
  • Indications Musculoskeletal pain; Osteoarthritis
  • Focus Therapeutic Use
  • Sponsors Mundipharma International
  • Most Recent Events

    • 15 Apr 2008 The expected completion date for this trial is now .
    • 10 Apr 2008 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 08 Oct 2006 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top